Optimisation des traitements hypolipémiants dans la prévention des maladies cardiovasculaires

Details

Supervisors

Gerber, Bernhard

Faculty

Faculté de pharmacie et des sciences biomédicales

Degree label

Master [120] en sciences pharmaceutiques, à finalité spécialisée

Abstract

enCardiovascular diseases, particularly those associated with elevated LDL-cholesterol, represent the leading cause of global morbidity and mortality. Yet, comparative research on recent clinical guidelines across major regions (Europe, USA, UK) and their real-world clinical implementation remains scarce. This thesis aims to bridge this gap by offering novel insights into dyslipidemia management. Ultimately, the findings of this study contribute to optimizing treatment strategies and improving cardiovascular prevention.